Oncolytics Biotech ONCY
NASDAQ ONCY
$0.83 +0.03 (+3.13%)
As of: Aug 21, 2026 · 12:27 PM EDT

Oncolytics Biotech (ONCY) Restructuring Costs (2024 - 2025)

Oncolytics Biotech (ONCY) posted quarterly Restructuring Costs of $88.65 for Q3 2025, up 4.25% year-over-year from $85.03 in Q3 2024, and up 4.25% quarter-over-quarter from $85.03 in Q3 2024.

Oncolytics Biotech (ONCY) Restructuring Costs (2024 - 2025) Analysis & Trends

Oncolytics Biotech (ONCY) has reported Restructuring Costs for 2 consecutive years, with $88.65 the latest figure, recorded in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.77 Bn 131.91 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 86.74 Bn 78.75 Bn 3.93 Bn
3 Argenx Se 65.36 Bn 60.17 Bn 1.37 Bn
4 Moderna 59.60 Bn 54.47 Bn 52.00 Mn
5 BeOne Medicines 42.10 Bn 37.00 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.80 Bn 28.49 Bn 992.69 Mn
7 BioNTech SE 28.13 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.54 Bn 26.38 Bn 358.27 Mn
9 Royalty Pharma 27.31 Bn 26.47 Bn -
10 Oncolytics Biotech 99.00 Mn 99.00 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2025 88.65
Sep 30, 2024 85.03